Your First Move For Thursday, July 22

Here’s our Fast Money Final Trade, where the traders give you the best plays for Thursday.

With inventory cycle coming to an end, says Brian Kelly of Kanundrum Capital, short CSX .

Tim Seymour of EmergingMoney.com likes Moscow-based steel producer Mechel .

Looking at the biotech space, Guy Adami of Drakon Capital likes Human Genome Sciences .

Joe Terranova of Vitrus Investment Partners recommends Precision Castparts .

On this dip, says Jon Najarian of optionMONSTER.com, Starbucks is a buy.

Click here to see other Final Trade posts.

Got something to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to fastmoney@cnbc.com.

Contact Fast Money

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET

Halftime Report

  • Bill Nygren, Oakmark Fund, explains why Apache, Bank of America and Google will be winners in 2015.

  • Nick Tiller, Sustainable America founder and chairman, tells CNBC's Kate Kelly oil prices are poised for a tradable rally. Tiller likes the Brent ETF and energy sector.

  • Discussing interesting trends contributing to the market's rally into year's end, with the FMHR trader Josh Brown and Dan Greenhaus, BTIG.